Technology is everywhere, in today’s world, and it is changing at a rapid pace that is sometimes hard to keep up with. Eric Lefkofsky knows a lot about the technology field, but he didn’t know a lot about cancer before he began his quest to gain a greater understanding of the disease that kills so many people. He discovered that the best way to learn about this field is to constantly be talking with the top people who know the most. He also knows how to encourage people to collaborate and share what they know, and that way is to build a community. Living in Chicago, Eric Lefkofsky, feels like his community is ready to take it up to the next level by employing more technology in every field possible. Specifically, he is ready to build a thriving health-tech industry right in the place he calls home.
Eric Lefkofsky is the co-founder and Chief Executive Officer of Tempus, which is a tech company that has created an operating system that helps physicians give their cancer patients personalized treatments. He attended the University of Michigan and graduated from the school before going on to receive his Juris Doctor from the University of Michigan Law School. His love for education and for the teaching of others inspired him to become an adjunct professor at the University of Chicago, and his love for his local community has motivated him to serve as a Trustee for The Museum of Science and Industry and World Business Chicago, The Art Institute of Chicago, and Lurie Children’s Hospital of Chicago.
Eric Lefkofsky came up with the idea for Tempus by watching a loved one go through the process of cancer treatment. It shocked him that the doctors didn’t rely on the same kind of technology that has been able to change so many other fields. When he went on a search to see if there was a company that was offering this kind of technology, he found that no one was. This is when he realized that it would be him and his new company that would be a part of changing the world for the better through technology that assists greatly in the fight against cancer.